Search

The article reports on the move of Merck KGAA, a German-based pharmaceutical company, to pay US$30 million to US$240 million for rights to a diabetes drug from Glenmark Pharmaceutical, a Mumbai, India-based drug company. The deal would include Merck to develop and commercialize the diabetes drug while Glenmark will retain the rights in the country. The diabetes drug is called GRC 8200 which is dipeptidyl peptidase IV inhibitors.

Focuses on the business operations of Dishman Pharmaceutical & Chemicals, a contract manufacturing in Ahmedabad, India. Company operation of Dishman; Annual sales of the company; Advantage of the low cost of employing chemists.

Cites the formation of an alliance between Rhone-Poulenc Foundation and the Archaeological Survey of India to preserve and restore two of the most significant monuments in India. Details on the monuments; Factors which affected the monuments.